Dr. Sabindra Pradhananga serves as Associate Director of Non-Clinical Development at Thryv Therapeutics. In this role, he leads and coordinates all non-clinical development activities across the company’s programs, including safety, DMPK, and in vivo efficacy studies, ensuring strategic integration and cross-functional alignment. His leadership supports the advancement of Thryv’s pipeline through rigorous study design, execution oversight, and data interpretation. In addition to his development responsibilities, Dr. Pradhananga remains actively engaged in research initiatives, where his scientific expertise and collaborative approach have contributed to multiple posters and peer-reviewed manuscripts.

Prior to joining Thryv, Dr. Pradhananga worked as a Quality Control Officer at Omnica Laboratories, where he contributed to ensuring that the manufactured pharmaceutical products complied with pharmacopeial regulations.

Dr. Pradhananga received his degree in Pharmacy from The T.N. Dr. M.G.R. Medical University in India. He holds a master's degree in Pathophysiology from Gachon University in South Korea, where he investigated the potency of caffeic acid as a potential anti-itch drug. He earned his Ph.D. in Neuroscience from Queen’s University in Canada, where he studied the mechanisms of interaction between gut microbiota and the vagus nerve and the role of this interaction in colitis.